Home / IRIX : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does IRIX make money? Does IRIX have pricing power? What's the Earnings Whisper? Will IRIX profit more as the business scales? What is IRIX's management track record? Is IRIX's current price justified?

IRIDEX Corporation

$0.64 -$0.53 (-45.30%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$0.66

Day Range

$0.62$0.66

Year Range

$0.62$1.65

Market Cap

11.08M

AVG Volume

67.58K

Trailing/Forward PE

-3.15/32

PEG ratio

0.03

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Revenue (USD) · TTM

IRIX Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
26 Q2	51.57M
26 Q1	52.58M
25 Q4	52.67M
25 Q3	50.65M
25 Q2	49.74M
25 Q1	48.8M
24 Q4	48.67M
24 Q3	48.43M
24 Q2	49.7M
24 Q1	49.92M

Net Income (USD) · TTM

IRIX Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
26 Q2	-3.55M
26 Q1	-3.27M
25 Q4	-4.44M
25 Q3	-5.09M
25 Q2	-5.45M
25 Q1	-7.13M
24 Q4	-8.91M
24 Q3	-11.04M
24 Q2	-10.86M
24 Q1	-10.94M

Operating Income (USD) · TTM

IRIX Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
26 Q2	-2.78M
26 Q1	-2.69M
25 Q4	-2.57M
25 Q3	-3.06M
25 Q2	-3.52M
25 Q1	-5.21M
24 Q4	-8.3M
24 Q3	-10.88M
24 Q2	-10.7M
24 Q1	-10.96M

EBITDA (USD) · TTM

IRIX EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
26 Q2	-1.71M
26 Q1	-1.63M
25 Q4	-2.83M
25 Q3	-3.55M
25 Q2	-3.99M
25 Q1	-5.69M
24 Q4	-7.42M
24 Q3	-9.08M
24 Q2	-8.83M
24 Q1	-8.78M

Cash Flows (USD) · TTM

IRIX Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
26 Q2	-1.77M
26 Q1	-2.45M
25 Q4	-2.18M
25 Q3	-3.99M
25 Q2	-5.89M
25 Q1	-6.81M
24 Q4	-7.3M
24 Q3	-7M
24 Q2	-5.79M
24 Q1	-5.62M

EPS (USD) · TTM

IRIX EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
26 Q2	-0.2
26 Q1	-0.19
25 Q4	-0.26
25 Q3	-0.3
25 Q2	-0.33
25 Q1	-0.43
24 Q4	-0.54
24 Q3	-0.67
24 Q2	-0.66
24 Q1	-0.67

Expenses (USD) · TTM

IRIX Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
26 Q2	21.34M
26 Q1	21.75M
25 Q4	21.86M
25 Q3	22.44M
25 Q2	23.2M
25 Q1	25.34M
24 Q4	27.82M
24 Q3	29.66M
24 Q2	30.85M
24 Q1	31.35M

Shares Outstanding (USD) · TTM

IRIX Shares Outstanding (USD) · TTM by quarter
Period	Shares Outstanding (USD) · TTM
26 Q2	-728K
26 Q1	-773K
25 Q4	-775K
25 Q3	-878K
25 Q2	-900K
25 Q1	-1.06M
24 Q4	-1.24M
24 Q3	-1.33M
24 Q2	-1.59M
24 Q1	-1.57M

Employee Count

IRIX Employee Count by quarter
Period	Employee Count
2026	93
2024	93
2023	111
2022	130
2022	119
2021	89
2019	11
2018	17
2017	38
2016	121

Free Cash Flow Yield

IRIX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-15.89%
Sep 26	-15.41%
Sep 26	-14.53%
Aug 26	-14.39%
Aug 26	-13.45%
Aug 26	-16.55%
Aug 26	-17.06%
Jul 26	-17.27%
Jul 26	-15.9%
Jul 26	-15.16%
Jul 26	-12.88%
Jul 26	-12.53%
Jun 26	-12.53%
Jun 26	-12.53%
Jun 26	-12.65%
Jun 26	-12.99%
May 26	-13.49%
May 26	-14.02%
May 26	-12.54%
May 26	-12.29%
May 26	-12.29%
Apr 26	-11.94%
Apr 26	-11.94%
Apr 26	-12.66%
Apr 26	-12.92%
Mar 26	-23.68%
Mar 26	-17.37%
Mar 26	-18.04%
Mar 26	-18.91%
Feb 26	-16.75%
Feb 26	-16.87%
Feb 26	-16.99%
Feb 26	-16.06%
Jan 26	-15.74%
Jan 26	-15.43%
Jan 26	-16.63%
Jan 26	-20.39%
Jan 26	-20.04%
Dec 25	-19.06%
Dec 25	-23.45%
Dec 25	-25.46%
Dec 25	-24.94%
Nov 25	-24.42%
Nov 25	-25.21%
Nov 25	-23.92%
Nov 25	-33.09%
Oct 25	-33.41%
Oct 25	-31.89%
Oct 25	-33.73%
Oct 25	-33.73%
Oct 25	-29.23%
Sep 25	-30.5%
Sep 25	-29.48%
Sep 25	-26.58%
Sep 25	-25.06%
Aug 25	-26.18%
Aug 25	-28.29%
Aug 25	-31.04%
Aug 25	-31.3%
Aug 25	-31.79%
Jul 25	-28.86%
Jul 25	-32.3%
Jul 25	-40.29%
Jul 25	-43.76%
Jun 25	-46.24%
Jun 25	-43.62%
Jun 25	-43.29%
Jun 25	-41.82%
May 25	-40.78%
May 25	-41.53%
May 25	-40.29%
May 25	-38.15%
May 25	-36.86%
Apr 25	-35.96%
Apr 25	-43.01%
Apr 25	-46.55%
Apr 25	-50.9%
Mar 25	-43.91%
Mar 25	-42.63%
Mar 25	-37.35%
Mar 25	-33.5%
Feb 25	-30.58%
Feb 25	-27.95%
Feb 25	-27.23%
Feb 25	-26.21%
Jan 25	-25.73%
Jan 25	-25.73%
Jan 25	-25.42%
Jan 25	-25.58%
Jan 25	-23.84%
Dec 24	-25.27%
Dec 24	-25.73%
Dec 24	-24.54%
Dec 24	-23.58%
Nov 24	-23.58%
Nov 24	-23.45%
Nov 24	-24.97%
Nov 24	-25.57%
Nov 24	-23.69%
Oct 24	-23.38%

Price to Sales

IRIX Price to Sales by quarter
Period	Price to Sales
Sep 26	0.22
Sep 26	0.22
Sep 26	0.24
Aug 26	0.24
Aug 26	0.25
Aug 26	0.28
Aug 26	0.27
Jul 26	0.27
Jul 26	0.29
Jul 26	0.31
Jul 26	0.36
Jul 26	0.37
Jun 26	0.37
Jun 26	0.37
Jun 26	0.37
Jun 26	0.36
May 26	0.35
May 26	0.33
May 26	0.33
May 26	0.34
May 26	0.34
Apr 26	0.35
Apr 26	0.35
Apr 26	0.33
Apr 26	0.32
Mar 26	0.33
Mar 26	0.45
Mar 26	0.44
Mar 26	0.42
Feb 26	0.47
Feb 26	0.47
Feb 26	0.46
Feb 26	0.49
Jan 26	0.5
Jan 26	0.51
Jan 26	0.47
Jan 26	0.39
Jan 26	0.39
Dec 25	0.41
Dec 25	0.34
Dec 25	0.31
Dec 25	0.32
Nov 25	0.32
Nov 25	0.31
Nov 25	0.33
Nov 25	0.36
Oct 25	0.35
Oct 25	0.37
Oct 25	0.35
Oct 25	0.35
Oct 25	0.41
Sep 25	0.39
Sep 25	0.4
Sep 25	0.45
Sep 25	0.47
Aug 25	0.45
Aug 25	0.42
Aug 25	0.38
Aug 25	0.45
Aug 25	0.44
Jul 25	0.48
Jul 25	0.43
Jul 25	0.35
Jul 25	0.32
Jun 25	0.3
Jun 25	0.32
Jun 25	0.32
Jun 25	0.33
May 25	0.34
May 25	0.34
May 25	0.35
May 25	0.39
May 25	0.41
Apr 25	0.42
Apr 25	0.35
Apr 25	0.32
Apr 25	0.29
Mar 25	0.34
Mar 25	0.34
Mar 25	0.39
Mar 25	0.43
Feb 25	0.47
Feb 25	0.52
Feb 25	0.53
Feb 25	0.55
Jan 25	0.56
Jan 25	0.56
Jan 25	0.57
Jan 25	0.56
Jan 25	0.61
Dec 24	0.57
Dec 24	0.56
Dec 24	0.59
Dec 24	0.61
Nov 24	0.61
Nov 24	0.62
Nov 24	0.58
Nov 24	0.46
Nov 24	0.49
Oct 24	0.5

Price/Operating Cashflow

IRIX Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
May 22	6.54
Apr 22	7.24
Apr 22	7.7
Apr 22	8.21
Apr 22	8.19
Apr 22	8.81
Mar 22	8.36
Mar 22	8.74
Mar 22	6.5
Mar 22	6.9
Feb 22	7.01
Feb 22	7.36
Feb 22	7.76
Feb 22	8.12
Jan 22	8.09
Jan 22	8.03
Jan 22	8.85
Jan 22	9.15
Dec 21	9.69
Dec 21	9.87
Dec 21	9.2
Dec 21	10
Dec 21	9.44
Nov 21	10.34
Nov 21	12.12
Nov 21	12.76
Nov 21	13.57
Oct 21	11.11
Oct 21	10.94
Oct 21	10.73
Oct 21	11.49
Oct 21	10.88
Sep 21	10.85
Sep 21	10.44
Sep 21	10.52
Sep 21	10.29
Aug 21	10.94
Aug 21	11.01
Aug 21	11.56
Aug 21	9.4
Jul 21	9.34
Jul 21	9.41
Jul 21	8.98
Jul 21	9.45
Jul 21	10.17
Jun 21	10.57
Jun 21	10
Jun 21	11.05
Jun 21	10.85
May 21	11.22
May 21	11
May 21	10.7

Price to Book

IRIX Price to Book by quarter
Period	Price to Book
Sep 26	3.06
Sep 26	3.15
Sep 26	3.34
Aug 26	3.37
Aug 26	3.61
Aug 26	3.13
Aug 26	3.04
Jul 26	3
Jul 26	3.26
Jul 26	3.42
Jul 26	4.02
Jul 26	4.13
Jun 26	4.13
Jun 26	4.13
Jun 26	4.1
Jun 26	3.99
May 26	3.84
May 26	3.69
May 26	3.53
May 26	3.6
May 26	3.6
Apr 26	3.7
Apr 26	3.7
Apr 26	3.49
Apr 26	3.42
Mar 26	3.6
Mar 26	4.91
Mar 26	4.72
Mar 26	4.51
Feb 26	5.09
Feb 26	5.05
Feb 26	5.01
Feb 26	5.31
Jan 26	5.41
Jan 26	5.52
Jan 26	5.12
Jan 26	4.18
Jan 26	4.25
Dec 25	4.47
Dec 25	3.63
Dec 25	3.35
Dec 25	3.42
Nov 25	3.49
Nov 25	3.38
Nov 25	3.56
Nov 25	2.94
Oct 25	2.91
Oct 25	3.05
Oct 25	2.88
Oct 25	2.88
Oct 25	3.33
Sep 25	3.19
Sep 25	3.3
Sep 25	3.66
Sep 25	3.88
Aug 25	3.71
Aug 25	3.44
Aug 25	3.13
Aug 25	25.52
Aug 25	25.13
Jul 25	27.68
Jul 25	24.74
Jul 25	19.83
Jul 25	18.26
Jun 25	17.28
Jun 25	18.32
Jun 25	18.46
Jun 25	19.11
May 25	19.59
May 25	19.24
May 25	19.83
May 25	9.12
May 25	9.44
Apr 25	9.68
Apr 25	8.09
Apr 25	7.48
Apr 25	6.84
Mar 25	7.93
Mar 25	6.26
Mar 25	7.14
Mar 25	7.96
Feb 25	8.72
Feb 25	9.55
Feb 25	9.8
Feb 25	10.18
Jan 25	10.37
Jan 25	10.37
Jan 25	10.49
Jan 25	10.43
Jan 25	11.19
Dec 24	10.56
Dec 24	10.37
Dec 24	10.87
Dec 24	11.32
Nov 24	11.32
Nov 24	11.38
Nov 24	10.68
Nov 24	5.33
Nov 24	5.75
Oct 24	5.83

No video analysis for this stock yet. Request one from our team.

News: IRIX

zacks.com · 25 Aug 2026

IRIDEX Q2 Loss Widens Y/Y as Retina Weakness Weighs, Stock Down 15%

IRIX's Q2 loss per share widens year over year and revenues decline as Middle East disruptions and reduced sell-through in China weigh on retina sales, offsetting continued growth in the Cyclo G6 product family.

seekingalpha.com · 18 Aug 2026

IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript

globenewswire.com · 18 Aug 2026

Iridex Reports Second Quarter 2026 Financial Results

MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 4, 2026.

globenewswire.com · 4 Aug 2026

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the second quarter 2026 and provide a business update after the close of trading on August 18, 2026.

globenewswire.com · 20 Jul 2026

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced the expansion of its EyeProGPO product offering to include the Company's line of EndoProbe® Handpieces.